This is the new MLex platform. Existing customers should continue to use the existing MLex platform until migrated.
For any queries, please contact Customer Services or your Account Manager. Dismiss

Lebedev papers' stake sales raise neither competition nor public-interest concerns, government told

( September 16, 2019, 14:00 GMT | Official Statement) -- MLex Summary: Media mogul Evgeny Lebedev's sale of minority stakes in his Evening Standard and Independent newspapers to Saudi-linked investors raise neither competition nor public-interest concerns, two watchdogs said in separate advisory reports — submitted earlier this year but published today — to the UK government's Department for Culture, Media and Sport. The Competition and Markets Authority said the sales don't meet a test for "substantial lessening of competition," and Ofcom said it didn't make an adverse finding on "accurate presentation of news ground or the free expression of opinion ground" — meaning that in-depth reference of the case is unwarranted. Last week, the government decided not to challenge a court ruling that stopped it from probing the investments into the newspapers.Statements follow. The reports are attached....

Prepare for tomorrow’s regulatory change, today

MLex identifies risk to business wherever it emerges, with specialist reporters across the globe providing exclusive news and deep-dive analysis on the proposals, probes, enforcement actions and rulings that matter to your organization and clients, now and in the longer term.


Know what others in the room don’t, with features including:

  • Daily newsletters for Antitrust, M&A, Trade, Data Privacy & Security, Technology, AI and more
  • Custom alerts on specific filters including geographies, industries, topics and companies to suit your practice needs
  • Predictive analysis from expert journalists across North America, the UK and Europe, Latin America and Asia-Pacific
  • Curated case files bringing together news, analysis and source documents in a single timeline

Experience MLex today with a 14-day free trial.

Start Free Trial

Already a subscriber? Click here to login